Sphingolipid metabolism and obesity-induced inflammation

Frontiers in Endocrinology

Volumn 4, Issue JUN, 2013, Pages

  Kang, Se Chan ^a   Kim, Bo Rahm ^a   Lee, Su Yeon ^a   Park, Tae Sik ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

Atherosclerosis; Cardiomyopathy; Ceramide; Diabetes; Fatty liver; Inflammation; Obesity

Indexed keywords

3 KETOSPHINGANINE REDUCTASE; ADIPONECTIN; C REACTIVE PROTEIN; CARNITINE PALMITOYLTRANSFERASE I; CERAMIDE; CERAMIDE 1 PHOSPHATE; CERAMIDE SYNTHASE; DIHYDROCERAMIDE DESATURASE; GLUCOCORTICOID; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROPEPTIDE Y; PEPTIDES AND PROTEINS; PHOSPHOPROTEIN PHOSPHATASE 2A; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE B; SPHINGOLIPID; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADIPOSE TISSUE; APOPTOSIS; ATHEROSCLEROSIS; CARDIOMYOPATHY; CELL METABOLISM; CELL PROLIFERATION; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FATTY LIVER; HOMEOSTASIS; HUMAN; HYPOTHALAMUS; INFLAMMATION; INSULIN RESISTANCE; LIPOTOXICITY; NONHUMAN; OBESITY; OXIDATIVE STRESS; PREVALENCE; PROTEIN EXPRESSION; PROTEIN METABOLISM; REVIEW; SIGNAL TRANSDUCTION; VASCULAR DISEASE;

EID: 84884199327     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2013.00067     Document Type: Review

References (132)

1. Abel, E. D., Litwin, S. E., and Sweeney, G. (2008). Cardiac remodeling in obesity. Physiol. Rev. 88, 389-419. doi: 10.1152/physrev.00017.2007
2. Adams, J. M. II, Pratipanawatr, T., Berria, R., Wang, E., DeFronzo, R. A., Sullards, M. C., et al. (2004). Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53, 25-31. doi: 10.2337/diabetes.53.1.25
3. Alderton, W. K., Cooper, C. E., and Knowles, R. G. (2001). Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357, 593-615. doi: 10.1042/0264- 6021:3570593
4. Amati, F., Dube, J. J., Alvarez-Carnero, E., Edreira, M. M., Chomentowski, P., Coen, P. M., et al. (2011). Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes?. Diabetes 60, 2588-2597. doi: 10.2337/db10-1221
5. Chang, Z. Q., Lee, S. Y., Kim, H. J., Kim, J. R., Kim, S. J., Hong, I. K., et al. (2011). Endotoxin activates de novo sphingolipid biosynthesis via nuclear factor kappa Bmediated upregulation of Sptlc2. Prostaglandins Other Lipid Mediat. 94, 44-52. doi: 10.1016/j.prostaglandins.2010.12.003
6. Chatterjee, S. (1994). Neutral sphingomyelinase action stimulates signal transduction of tumor necrosis factor-alpha in the synthesis of cholesteryl esters in human fibroblasts. J. Biol. Chem. 269, 879-882.
7. Chavez, J. A., Holland, W. L., Bar, J., Sandhoff, K., and Summers, S. A. (2005). Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling. J. Biol. Chem. 280, 20148-20153. doi: 10.1074/jbc.M412769200
8. Chavez, J. A., Knotts, T. A., Wang, L. P., Li, G., Dobrowsky, R. T., Florant, G. L., et al. (2003). A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J. Biol. Chem. 278, 10297-10303. doi: 10.1074/jbc.M212307200
9. Chavez, J. A., and Summers, S. A. (2010). Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms. Biochim. Biophys. Acta 1801, 252- 265. doi: 10.1016/j.bbalip.2009.09.015
10. Christiansen, T., Richelsen, B., and Bruun, J. M. (2005). Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int. J. Obes. (Lond.) 29, 146-150. doi: 10.1038/sj.ijo.0802839
11. Deevska, G. M., Rozenova, K. A., Giltiay, N. V., Chambers, M. A., White, J., Boyanovsky, B. B., et al. (2009). Acid sphingomyelinase deficiency prevents diet-induced hepatic triacylglycerol accumulation and hyperglycemia in mice. J. Biol. Chem. 284, 8359-8368. doi: 10.1074/jbc.M807800200
12. Dobrowsky, R. T., Kamibayashi, C., Mumby, M. C., and Hannun, Y. A. (1993). Ceramide activates heterotrimeric protein phosphatase 2A. J. Biol. Chem. 268, 15523- 15530.
13. Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., and Parks, E. J. (2005). Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115, 1343-1351. doi: 10.1172/JCI200523621
14. Dressler, K. A., Mathias, S., and Kolesnick, R. N. (1992). Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system. Science 255, 1715-1718. doi: 10.1126/science.1313189
15. Du, X., Edelstein, D., Obici, S., Higham, N., Zou, M. H., and Brownlee, M. (2006). Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J. Clin. Invest. 116, 1071-1080. doi: 10.1172/JCI23354
16. Eisenberg, S., Stein, Y., and Stein, O. (1969). Phospholipases in arterial tissue. IV. The role of phosphatide acyl hydrolase, lysophosphatide acyl hydrolase, and sphingomyelin choline phosphohydrolase in the regulation of phospholipid composition in the normal human aorta with age. J. Clin. Invest. 48, 2320-2329. doi: 10.1172/JCI106198
17. Fang, X., and Sweeney, G. (2006). Mechanisms regulating energy metabolism by adiponectin in obesity and diabetes. Biochem. Soc. Trans. 34, 798-801. doi: 10.1042/BST0340798
18. Farrell, G. C., and Larter, C. Z. (2006). Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43, S99-S112. doi: 10.1002/hep.20973
19. Feldstein, A. E., Werneburg, N. W., Canbay, A., Guicciardi, M. E., Bronk, S. F., Rydzewski, R., et al. (2004). Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 40, 185-194. doi: 10.1002/hep.20283
20. Ferrante, A. W. Jr. (2007). Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J. Intern. Med. 262, 408-414. doi: 10.1111/j.1365- 2796.2007.01852.x
21. Finkelstein, E. A., Trogdon, J. G., Cohen, J. W., and Dietz, W. (2009). Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff. (Millwood) 28, w822-w831. doi: 10.1377/hlthaff.28.5.w822
22. Flegal, K. M., Graubard, B. I., Williamson, D. F., and Gail, M. H. (2007). Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 298, 2028-2037. doi: 10.1001/jama.298.17.2028
23. Fried, S. K., Bunkin, D. A., and Greenberg, A. S. (1998). Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83, 847-850. doi: 10.1210/jc.83.3.847
24. Friedman, J. M., and Halaas, J. L. (1998). Leptin and the regulation of body weight in mammals. Nature 395, 763-770. doi: 10.1038/27376
25. Friedman, J. M., and Leibel, R. L. (1992). Tackling a weighty problem. Cell 69, 217-220. doi: 10.1016/0092-8674(92)90402-X
26. Futerman, A. H., and Hannun, Y. A. (2004). The complex life of simple sphingolipids. EMBO Rep. 5, 777-782. doi: 10.1038/sj.embor.7400208
27. Gao, S., Kinzig, K. P., Aja, S., Scott, K. A., Keung, W., Kelly, S., et al. (2007). Leptin activates hypothalamic acetyl-CoA carboxylase to inhibit food intake. Proc. Natl. Acad. Sci. U.S.A. 104, 17358-17363. doi: 10.1073/pnas.0708385104
28. Gao, S., and Lane, M. D. (2003). Effect of the anorectic fatty acid synthase inhibitor C75 on neuronal activity in the hypothalamus and brainstem. Proc. Natl. Acad. Sci. U.S.A. 100, 5628-5633. doi: 10.1073/pnas.1031698100
29. Gao, S., Zhu, G., Gao, X., Wu, D., Carrasco, P., Casals, N., et al. (2011). Important roles of brain-specific carnitine palmitoyltransferase and ceramide metabolism in leptin hypothalamic control of feeding. Proc. Natl. Acad. Sci. U.S.A. 108, 9691-9696. doi: 10.1073/pnas.1103267108
30. Guyton, J. R., and Klemp, K. F. (1996). Development of the lipid-rich core in human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 16, 4-11. doi: 10.1161/01.ATV.16.1.4
31. Hajduch, E., Balendran, A., Batty, I. H., Litherland, G. J., Blair, A. S., Downes, C. P., et al. (2001). Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. Diabetologia 44, 173-183. doi: 10.1007/s001250051596
32. Hakomori, S. (1981). Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu. Rev. Biochem. 50, 733-764. doi: 10.1146/annurev.bi.50.070181.003505
33. Hannun, Y. A., and Obeid, L. M. (2008). Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 9, 139-150. doi: 10.1038/nrm2329
34. Haus, J. M., Kashyap, S. R., Kasumov, T., Zhang, R., Kelly, K. R., Defronzo, R. A., et al. (2009). Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 58, 337-343. doi: 10.2337/db08-1228
35. He, W., Lam, T. K., Obici, S., and Rossetti, L. (2006). Molecular disruption of hypothalamic nutrient sensing induces obesity. Nat. Neurosci. 9, 227-233. doi: 10.1038/nn1626
36. Hoehn, K. L., Hohnen-Behrens, C., Cederberg, A., Wu, L. E., Turner, N., Yuasa, T., et al. (2008). IRS1-independent defects define major nodes of insulin resistance. Cell Metab. 7, 421-433. doi: 10.1016/j.cmet.2008.04.005
37. Hoff, H. F., and Morton, R. E. (1985). Lipoproteins containing apo B extracted from human aortas. Structure and function. Ann. N. Y. Acad. Sci. 454, 183-194.
38. Hojjati, M. R., Li, Z., Zhou, H., Tang, S., Huan, C., Ooi, E., et al. (2005). Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice. J. Biol. Chem. 280, 10284-10289. doi: 10.1074/jbc.M412348200
39. Holland, W. L., Bikman, B. T., Wang, L. P., Yuguang, G., Sargent, K. M., Bulchand, S., et al. (2011a). Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J. Clin. Invest. 121, 1858-1870. doi: 10.1172/JCI43378
40. Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., et al. (2011b). Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat. Med. 17, 55-63. doi: 10.1038/nm.2277
41. Holland, W. L., Brozinick, J. T., Wang, L. P., Hawkins, E. D., Sargent, K. M., Liu, Y., et al. (2007). Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab. 5, 167-179. doi: 10.1016/j.cmet.2007.01.002
42. Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., and Spiegelman, B. M. (1995). Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95, 2409-2415. doi: 10.1172/JCI117936
43. Hotamisligil, G. S., Shargill, N. S., and Spiegelman, B. M. (1993). Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91. doi: 10.1126/science.7678183
44. Hotamisligil, G. S., and Spiegelman, B. M. (1994). Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43, 1271-1278. doi: 10.2337/diabetes.43.11.1271
45. Jarrar, M. H., Baranova, A., Collantes, R., Ranard, B., Stepanova, M., Bennett, C., et al. (2008). Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 27, 412-421. doi: 10.1111/j.1365-2036.2007.03586.x
46. Jeong, T., Schissel, S. L., Tabas, I., Pownall, H. J., Tall, A. R., and Jiang, X. (1998). Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. J. Clin. Invest. 101, 905-912. doi: 10.1172/JCI870
47. Jiang, X. C., Paultre, F., Pearson, T. A., Reed, R. G., Francis, C. K., Lin, M., et al. (2000). Plasma sphingomyelin level as a risk factor for coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 20, 2614-2618. doi: 10.1161/01.ATV.20.12.2614
48. Johns, D. G., Charpie, J. R., and Webb, R. C. (1998). Is ceramide signaling a target for vascular therapeutic intervention?. Curr. Pharm. Des. 4, 481-488.
49. Jung, S. H., Park, H. S., Kim, K. S., Choi, W. H., Ahn, C. W., Kim, B. T., et al. (2008). Effect of weight loss on some serum cytokines in human obesity: increase in IL- 10 after weight loss. J. Nutr. Biochem. 19, 371-375. doi: 10.1016/j.jnutbio.2007.05.007
50. Kadowaki, T., Yamauchi, T., and Kubota, N. (2008). The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. FEBS Lett. 582, 74-80. doi: 10.1016/j.febslet.2007.11.070
51. Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K., Ueki, K., and Tobe, K. (2006). Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 116, 1784-1792. doi: 10.1172/JCI29126
52. Kawamura, N., Kubota, T., Kawano, S., Monden, Y., Feldman, A. M., Tsutsui, H., et al. (2005). Blockade of NF-kappaB improves cardiac function and survival without affecting inflammation in TNF-alpha-induced cardiomyopathy. Cardiovasc. Res. 66, 520-529. doi: 10.1016/j.cardiores.2005.02.007
53. Kim, C. H., and Younossi, Z. M. (2008). Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome. Cleve. Clin. J. Med. 75, 721-728. doi: 10.3949/ccjm.75.10.721
54. Kobayashi, H., Ouchi, N., Kihara, S., Walsh, K., Kumada, M., Abe, Y., et al. (2004). Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ. Res. 94, e27-e31. doi: 10.1161/01.RES.0000119921.86460.37
55. Kolak, M., Westerbacka, J., Velagapudi, V. R., Wagsater, D., Yetukuri, L., Makkonen, J., et al. (2007). Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 56, 1960-1968. doi: 10.2337/db07-0111
56. Kraegen, E. W., Cooney, G. J., Ye, J. M., Thompson, A. L., and Furler, S. M. (2001). The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity. Exp. Clin. Endocrinol. Diabetes 109(Suppl. 2), S189-S201. doi: 10.1055/s-2001-18581
57. Kummerow, F. A., Cook, L. S., Wasowicz, E., and Jelen, H. (2001). Changes in the phospholipid composition of the arterial cell can result in severe atherosclerotic lesions. J. Nutr. Biochem. 12, 602-607. doi: 10.1016/S0955-2863(01)00181-4
58. Lee, S. Y., Kim, J. R., Hu, Y., Khan, R., Kim, S. J., Bharadwaj, K. G., et al. (2012). Cardiomyocyte specific deficiency of serine palmitoyltransferase subunit 2 reduces ceramide but leads to cardiac dysfunction. J. Biol. Chem. 287, 18429-18439. doi: 10.1074/jbc.M111.296947
59. Li, Z., Park, T. S., Li, Y., Pan, X., Iqbal, J., Lu, D., et al. (2009). Serine palmitoyltransferase (SPT) deficient mice absorb less cholesterol. Biochim. Biophys. Acta 1791, 297-306. doi: 10.1016/j.bbalip.2009.01.010
60. Liu, J., Huan, C., Chakraborty, M., Zhang, H., Lu, D., Kuo, M. S., et al. (2009). Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice. Circ. Res. 105, 295-303. doi: 10.1161/CIRCRESAHA.109.194613
61. Liu, P., Leffler, B. J., Weeks, L. K., Chen, G., Bouchard, C. M., Strawbridge, A. B., et al. (2004). Sphingomyelinase activates GLUT4 translocation via a cholesteroldependent mechanism. Am. J. Physiol. Cell Physiol. 286, C317-C329. doi: 10.1152/ajpcell.00073.2003
62. Liu, Y., Retnakaran, R., Hanley, A., Tungtrongchitr, R., Shaw, C., and Sweeney, G. (2007). Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects. J. Clin. Endocrinol. Metab. 92, 4313-4318. doi: 10.1210/jc.2007- 0890
63. Loftus, T. M., Jaworsky, D. E., Frehywot, G. L., Townsend, C. A., Ronnett, G. V., Lane, M. D., et al. (2000). Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288, 2379-2381. doi: 10.1126/science.288.5475.2379
64. Lopez, M., Lelliott, C. J., Tovar, S., Kimber, W., Gallego, R., Virtue, S., et al. (2006). Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA. Diabetes 55, 1327-1336. doi: 10.2337/db05-1356
65. Matsuzawa, Y. (2010). Adiponectin: a key player in obesity related disorders. Curr. Pharm. Des. 16, 1896-1901. doi: 10.2174/138161210791208893
66. Memon, R. A., Holleran, W. M., Moser, A. H., Seki, T., Uchida, Y., Fuller, J., et al. (1998). Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin. Arterioscler. Thromb. Vasc. Biol. 18, 1257-1265. doi: 10.1161/01.ATV.18.8.1257
67. Mohamed-Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., et al. (1997). Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab. 82, 4196-4200. doi: 10.1210/jc.82.12.4196
68. Morad, S. A., and Cabot, M. C. (2013). Ceramide-orchestrated signalling in cancer cells. Nat. Rev. Cancer 13, 51-65. doi: 10.1038/nrc3398
69. Morales-Ruiz, M., Lee, M. J., Zollner, S., Gratton, J. P., Scotland, R., Shiojima, I., et al. (2001). Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells. J. Biol. Chem. 276, 19672-19677. doi: 10.1074/jbc.M009993200
70. Neuschwander-Tetri, B. A., and Caldwell, S. H. (2003). Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37, 1202-1219. doi: 10.1053/jhep.2003.50193
71. Newman, H. A., McCandless, C. E., and Zilversmit, D. B. (1961). The synthesis of C14-lipids in rabbit atheromatous lesions. J. Biol. Chem. 236, 1264-1268.
72. Nievelstein, P. F., Fogelman, A. M., Mottino, G., and Frank, J. S. (1991). Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein. A deep-etch and immunolocalization study of ultrarapidly frozen tissue. Arterioscler. Thromb. 11, 1795-1805. doi: 10.1161/01.ATV.11.6.1795
73. Obici, S., Feng, Z., Arduini, A., Conti, R., and Rossetti, L. (2003). Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat. Med. 9, 756-761. doi: 10.1038/nm873
74. Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., et al. (2000). Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NFkappaB signaling through a cAMP-dependent pathway. Circulation 102, 1296-1301. doi: 10.1161/01.CIR.102.11.1296
75. Park, T. S., Hu, Y., Noh, H. L., Drosatos, K., Okajima, K., Buchanan, J., et al. (2008a). Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J. Lipid Res. 49, 2101- 2112. doi: 10.1194/jlr.M800147-JLR200
76. Park, T. S., Rosebury, W., Kindt, E. K., Kowala, M. C., and Panek, R. L. (2008b). Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic apoE-deficient mice. Pharmacol. Res. 58, 45-51. doi: 10.1016/j.phrs.2008.06.005
77. Park, T. S., Panek, R. L., Mueller, S. B., Hanselman, J. C., Rosebury, W. S., Robertson, A. W., et al. (2004). Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 110, 3465-3471. doi: 10.1161/01.CIR.0000148370.60535.22
78. Peng, Y., Rideout, D., Rakita, S., Sajan, M., Farese, R., You, M., et al. (2009). Downregulation of adiponectin/AdipoR2 is associated with steatohepatitis in obese mice. J. Gastrointest. Surg. 13, 2043-2049. doi: 10.1007/s11605-009-1032-2
79. Perreault, M., and Marette, A. (2001). Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat. Med. 7, 1138-1143. doi: 10.1038/nm1001-1138
80. Pettus, B. J., Chalfant, C. E., and Hannun, Y. A. (2002). Ceramide in apoptosis: an overview and current perspectives. Biochim. Biophys. Acta 1585, 114-125. doi: 10.1016/S1388-1981(02)00331-1
81. Phillips, G. B., and Dodge, J. T. (1967). Composition of phospholipids and of phospholipid fatty acids of human plasma. J. Lipid Res. 8, 676-681.
82. Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setala, K., Walsh, A., Verstuyft, J. G., et al. (1992). Severe hypercholesterolemia and atherosclerosis in apolipoprotein Edeficient mice created by homologous recombination in ES cells. Cell 71, 343-353. doi: 10.1016/0092-8674(92)90362-G
83. Portman, O. W., and Illingworth, D. R. (1976). Arterial metabolism in primates. Primates Med. 9, 145-223.
84. Powell, D. J., Hajduch, E., Kular, G., and Hundal, H. S. (2003). Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanism. Mol. Cell. Biol. 23, 7794-7808. doi: 10.1128/MCB.23.21.7794-7808.2003
85. Powell, D. J., Turban, S., Gray, A., Hajduch, E., and Hundal, H. S. (2004). Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. Biochem. J. 382, 619-629. doi: 10.1042/BJ20040139
86. Reyna, S. M., Ghosh, S., Tantiwong, P., Meka, C. S., Eagan, P., Jenkinson, C. P., et al. (2008). Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Diabetes 57, 2595-2602. doi: 10.2337/db08-0038
87. Riad, A., Bien, S., Gratz, M., Escher, F., Westermann, D., Heimesaat, M. M., et al. (2008). Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice. Eur. J. Heart Fail. 10, 233-243. doi: 10.1016/j.ejheart.2008.01.004
88. Ross, R. (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809. doi: 10.1038/362801a0
89. Ruvolo, P. P. (2003). Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol. Res. 47, 383-392. doi: 10.1016/S1043-6618 (03)00050-1
90. Samad, F., Hester, K. D., Yang, G., Hannun, Y. A., and Bielawski, J. (2006). Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 55, 2579-2587. doi: 10.2337/db06-0330
91. Schilling, J. D., Machkovech, H. M., He, L., Sidhu, R., Fujiwara, H., Weber, K., et al. (2013). Palmitate and lipopolysaccharide trigger synergistic ceramide production in primary macrophages. J. Biol. Chem. 288, 2923-2932. doi: 10.1074/jbc.M112.419978
92. Schissel, S. L., Jiang, X., Tweedie-Hardman, J., Jeong, T., Camejo, E. H., Najib, J., et al. (1998). Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J. Biol. Chem. 273, 2738-2746. doi: 10.1074/jbc.273.5.2738
93. Schissel, S. L., Tweedie-Hardman, J., Rapp, J. H., Graham, G., Williams, K. J., and Tabas, I. (1996). Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J. Clin. Invest. 98, 1455-1464. doi: 10.1172/JCI118934
94. Schlitt, A., Blankenberg, S., Yan, D., von Gizycki, H., Buerke, M., Werdan, K., et al. (2006). Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease. Nutr. Metab. (Lond.) 3, 5.
95. Schutze, S., Potthoff, K., Machleidt, T., Berkovic, D., Wiegmann, K., and Kronke, M. (1992). TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71, 765-776. doi: 10.1016/0092-8674(92)90553-O
96. Schutze, S., Wiegmann, K., Machleidt, T., and Kronke, M. (1995). TNF-induced activation of NF-kappa B. Immunobiology 193, 193-203. doi: 10.1016/S0171-2985 (11)80543-7
97. Schwartz, M. W., Woods, S. C., Porte, D. Jr., Seeley, R. J., and Baskin, D. G. (2000). Central nervous system control of food intake. Nature 404, 661-671.
98. Shetty, S., Kusminski, C. M., and Scherer, P. E. (2009). Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies. Trends Pharmacol. Sci. 30, 234-239. doi: 10.1016/j.tips.2009.02.004
99. Shimabukuro, M., Higa, M., Zhou, Y. T., Wang, M. Y., Newgard, C. B., and Unger, R. H. (1998). Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J. Biol. Chem. 273, 32487-32490. doi: 10.1074/jbc.273.49.32487
100. Smith, E. B. (1960). Intimal and medial lipids in human aortas. Lancet 1, 799-803. doi: 10.1016/S0140-6736(60)90680-2
101. Spiegel, S., and Milstien, S. (2003). Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 4, 397-407. doi: 10.1038/nrm1103
102. Steinberg, H. O., Paradisi, G., Hook, G., Crowder, K., Cronin, J., and Baron, A. D. (2000). Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes 49, 1231-1238. doi: 10.2337/diabetes.49.7.1231
103. Stone, P. H., Muller, J. E., Hartwell, T., York, B. J., Rutherford, J. D., Parker, C. B., et al. (1989). The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. J. Am. Coll. Cardiol. 14, 49-57. doi: 10.1016/0735-1097(89)90053-3
104. Sugiura, M., Kono, K., Liu, H., Shimizugawa, T., Minekura, H., Spiegel, S., et al. (2002). Ceramide kinase, a novel lipid kinase. Molecular cloning and functional characterization. J. Biol. Chem. 277, 23294-23300. doi: 10.1074/jbc.M201535200
105. Summers, S. A. (2006). Ceramides in insulin resistance and lipotoxicity. Prog. Lipid Res. 45, 42-72. doi: 10.1016/j.plipres.2005.11.002
106. Summers, S. A. (2010). Sphingolipids and insulin resistance: the five Ws. Curr. Opin. Lipidol. 21, 128-135. doi: 10.1097/MOL.0b013e3283373b66
107. Summers, S. A., Garza, L. A., Zhou, H., and Birnbaum, M. J. (1998). Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol. Cell. Biol. 18, 5457-5464.
108. Symons, J. D., McMillin, S. L., Riehle, C., Tanner, J., Palionyte, M., Hillas, E., et al. (2009). Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure. Circ. Res. 104, 1085-1094. doi: 10.1161/CIRCRESAHA.108.189316
109. Tabas, I., Williams, K. J., and Boren, J. (2007). Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116, 1832-1844. doi: 10.1161/CIRCULATIONAHA.106.676890
110. Ueki, K., Kondo, T., Tseng, Y. H., and Kahn, C. R. (2004). Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc. Natl. Acad. Sci. U.S.A. 101, 10422-10427. doi: 10.1073/pnas.0402511101
111. Unger, R. H. (2003). Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 144, 5159-5165. doi: 10.1210/en.2003-0870
112. Vandenabeele, P., Declercq, W., Beyaert, R., and Fiers, W. (1995). Two tumour necrosis factor receptors: structure and function. Trends Cell Biol. 5, 392-399. doi: 10.1016/S0962-8924(00)89088-1
113. Visser, M., Bouter, L. M., McQuillan, G. M., Wener, M. H., and Harris, T. B. (1999). Elevated C-reactive protein levels in overweight and obese adults. JAMA 282, 2131-2135. doi: 10.1001/jama.282.22.2131
114. Waki, H., Yamauchi, T., Kamon, J., Kita, S., Ito, Y., Hada, Y., et al. (2005). Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 146, 790-796. doi: 10.1210/en.2004-1096
115. Wang, Y., Lam, K. S., Chan, L., Chan, K. W., Lam, J. B., Lam, M. C., et al. (2006). Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex. J. Biol. Chem. 281, 16391-16400. doi: 10.1074/jbc.M513907200
116. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., and Ferrante, A. W. Jr. (2003). Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808. doi: 10.1172/JCI19246
117. Williams, K. J., and Tabas, I. (1995). The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15, 551-561. doi: 10.1161/01.ATV.15.5.551
118. Williams, K. J., and Tabas, I. (1998). The response-to-retention hypothesis of atherogenesis reinforced. Curr. Opin. Lipidol. 9, 471-474. doi: 10.1097/00041433- 199810000-00012
119. Witztum, J. L., and Steinberg, D. (1991). Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88, 1785-1792. doi: 10.1172/JCI115499
120. Wolfgang, M. J., Cha, S. H., Sidhaye, A., Chohnan, S., Cline, G., Shulman, G. I., et al. (2007). Regulation of hypothalamic malonyl-CoA by central glucose and leptin. Proc. Natl. Acad. Sci. U.S.A. 104, 19285-19290. doi: 10.1073/pnas.0709778104
121. Wolfgang, M. J., Kurama, T., Dai, Y., Suwa, A., Asaumi, M., Matsumoto, S., et al. (2006). The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis. Proc. Natl. Acad. Sci. U.S.A. 103, 7282-7287. doi: 10.1073/pnas.0602205103
122. Wu, Y., Song, P., Xu, J., Zhang, M., and Zou, M. H. (2007). Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase. J. Biol. Chem. 282, 9777-9788. doi: 10.1074/jbc.M608310200
123. Yang, G., Badeanlou, L., Bielawski, J., Roberts, A. J., Hannun, Y. A., and Samad, F. (2009). Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome. Am. J. Physiol. Endocrinol. Metab. 297, E211-E224. doi: 10.1152/ajpendo.91014.2008
124. Yang, W. S., Lee, W. J., Funahashi, T., Tanaka, S., Matsuzawa, Y., Chao, C. L., et al. (2001). Weight reduction increases plasma levels of an adipose-derived antiinflammatory protein, adiponectin. J. Clin. Endocrinol. Metab. 86, 3815-3819. doi: 10.1210/jc.86.8.3815
125. Yetukuri, L., Katajamaa, M., Medina-Gomez, G., Seppanen-Laakso, T., Vidal-Puig, A., and Oresic, M. (2007). Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis. BMC Syst. Biol. 1, 12. doi: 10.1186/1752-0509-1-12
126. Yla-Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., Butler, S., et al. (1989). Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84, 1086-1095. doi: 10.1172/JCI114271
127. Yokoyama, M., Yagyu, H., Hu, Y., Seo, T., Hirata, K., Homma, S., et al. (2004). Apolipoprotein B production reduces lipotoxic cardiomyopathy, studies in heartspecific lipoprotein lipase transgenic mouse. J. Biol. Chem. 279, 4204-4211. doi: 10.1074/jbc.M311995200
128. Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z. W., Karin, M., et al. (2001). Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293, 1673-1677. doi: 10.1126/science.1061620
129. Zhang, Q. J., Holland, W. L., Wilson, L., Tanner, J. M., Kearns, D., Cahoon, J. M., et al. (2012). Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex. Diabetes 61, 1848-1859. doi: 10.2337/db11-1399
130. Zhang, S. H., Reddick, R. L., Piedrahita, J. A., and Maeda, N. (1992). Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258, 468-471. doi: 10.1126/science.1411543
131. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., and Friedman, J. M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432. doi: 10.1038/372425a0
132. Zilversmit, D. B., McCandless, C. E., Jordan, P. H., Henly, W. S., and Ackerman, R. F. (1961). The synthesis of phospholipids in human atheromatous lesions. Circulation 23, 370-375. doi: 10.1161/01.CIR.23.3.370